MPAL.L is trading 5% up at $4.20 following a sharp bounce from its June 30 drop to $4.00.
- The recovery comes amid heavy recent volatility, though no fresh company-specific news or regulatory filings have been flagged to explain the move.
- Gains appear driven by sustained investor interest in MedPal AI’s GLP-1 weight management exposure and previous UK regulatory approval rather than a new catalyst.